| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8246708 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages | 
Abstract
												Conclusions: These preclinical studies suggest that ZD6126 can augment the radiation response of proliferating endothelial H&N and lung cancer cells. These results complement recent reports suggesting the potential value of combining radiation with vascular targeting/antiangiogenic agents.
											Related Topics
												
													Physical Sciences and Engineering
													Physics and Astronomy
													Radiation
												
											Authors
												Tien M.D., Shyhmin Ph.D., Eric M.S., Jens C. Ph.D., Paul M. M.D., 
											